Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2007-07-10

Clinical Trial Update: A Study to Evaluate the Use of Nitazoxanide to Treat Cryptosporidiosis [NA]

View source ↗

Summary

A clinical trial assessing nitazoxanide for treatment of cryptosporidiosis, including infections in individuals with HIV; the current status is unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Alinia (Nitazoxanide)

Snippet

Sponsor: Romark Laboratories L.C. | Conditions: Cryptosporidiosis, HIV Infections | NA | Status: UNKNOWN